Cell & Gene Therapy CDMO Partnerships

Features

Building Cell Therapy the Right Way

Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.

SPONSOR

Big Cell Therapy Ambitions Start Here

Helping ambitious cell therapy companies grow from early development to commercial manufacturing.

Features

Improving Cell and Gene Therapy Scale-Up with a Digital-First Approach

Notable pitfalls in the cell and gene therapy space can be addressed with specific aspects of digitalization.

Online Exclusives

Cell and Gene Therapy Manufacturing Challenges & Solutions

Addressing major obstacles in the development and manufacturing of CGTs with Jon Ellis, CEO of Trenchant BioSystems.

SPONSOR

From Capacity to Coordination: The Hidden Bottleneck in Scaling CGT

As CGT programs move toward scale, the bigger challenge is no longer capacity alone, but keeping the full supply chain aligned across sites, vendors, and handoffs.

Expert’s Opinion

Manufacturing Agreements in the Cell & Gene Therapy Space

Tips to avoid IP contamination in manufacturing agreements such as using limits on liability/liability caps and confidentiality.

Solution Center SPOTLIGHT

Patheon Thermo Fisher Scientific

Thermo Fisher Scientific provides sterile fill-finish development and manufacturing for biologics, small molecules and mRNA therapeutics, supporting programs from preclinical and first-in-human stages through commercial supply. Capabilities span liquid and lyophilized vials, prefilled syringes, cartridges, and small- and large-volume parenterals.

Solution Content Center SPOTLIGHT

Upperton

Upperton is a UK-based CDMO providing integrated contract development and manufacturing services. Specializing in oral, nasal, pulmonary and sterile dosage forms, Upperton offers a comprehensive range of services designed to support the progression of a molecule from early feasibility through to formulation development, clinical trial manufacture and commercial manufacture.